IGC Pharma Statistics
NYSE: IGCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.280.00 (0.00%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 0.2859 +1.20%
IGC Pharma by the numbers
IGC Pharma has a market capitalization of $28.9 million based on 103.38M shares outstanding. With trailing EPS of $-0.07, IGC Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.1% below its 50-day average and 1.5% below its 200-day average.
Average daily trading volume is 710.47K shares, or about $198,931 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IGC valuation vs. peer median
| Metric | IGC | Peer median | Difference |
|---|---|---|---|
| Market cap | $28.95M | $29.59M | -2% |
| Avg. volume | 710.47K | 110.32K | +544% |
Peer median across 8 companies: CNTX, GRDX, RNAZ, MIRA, IMMP, NXTC, MCRB, ABVC.
Valuation
- Market cap
- $28.95M
- EPS (TTM)
- $-0.07
- Shares outstanding
- 103.38M
Price and trading
- Previous close
- 0.28
- Open
- 0.289
- Day range
- 0.28 – 0.29
- 52-week range
- 0.24 – 0.45
- 52-week change
- -31.71%
- 50-day moving average
- 0.2804
- 200-day moving average
- 0.2842
- Beta
- —
- Volume
- 299.91K
- Average volume
- 710.47K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 28.95M
- Forward Pe
- -3.50
- Eps
- -0.07
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 0.45
- Week52 Low
- 0.24
- Avg Volume
- 710.47K
- Shares Outstanding
- 103.38M
- Ma50
- 0.28
- Ma200
- 0.28
- Pct From52w High
- -37.78%
- Pct From52w Low
- 16.67%